Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Annual Report & Annual Information Form Published

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Mar 30, 2023 10:49pm

86 Views

Post# 35370948

RE:RE:Annual Report & Annual Information Form Published

Does what make sense Wofat?

I don't see a question except ... hurry up and wait?

What are you asking to be validated?

And if you want "validation," then you should ask Samira. No one else is going to give you that.
All you get here is cheerleading - OR - anger.

Hahaha !

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023